Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascites

• Published in: Scientific reports Vol. 13; no. 1; pp. 23001 - 11
• Main Authors: Höppner, Jim, Krohn, Sandra, van den Munckhof, Ellen H. A., Kallies, René, Herber, Adam, Zeller, Katharina, Tünnemann, Jan, Matz-Soja, Madlen, Chatzinotas, Antonis, Böhm, Stephan, Hoffmeister, Albrecht, Berg, Thomas, Engelmann, Cornelius
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 27.12.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/1647/2163; 692/4020/4021/1607/1604; Ascites; Bacteria; Blood; Cirrhosis; Deoxyribonucleic acid; DNA; Dysbacteriosis; Humanities and Social Sciences; Intestinal microflora; Liver; Liver cirrhosis; Liver diseases; Microbiota; multidisciplinary; rRNA 16S; Science; Science (multidisciplinary); Small intestine; Streptococcus; Streptococcus infections; Translocation
• DOI: 10.1038/s41598-023-49505-3
• ISSN: 2045-2322

Small intestinal bacterial overgrowth and compositional changes of intestinal microbiota are pathomechanistic factors in liver cirrhosis leading to bacterial translocation and infectious complications. We analyzed the quantity and composition of duodenal bacterial DNA (bactDNA) in relation to bactDNA in blood and ascites of patients with liver cirrhosis. Duodenal fluid and corresponding blood and ascites samples from 103 patients with liver cirrhosis were collected. Non-liver disease patients (n = 22) served as controls. BactDNA was quantified by 16S-rRNA gene-based PCR. T-RFLP and 16S-rRNA amplicon sequencing were used to analyze bacterial composition. Duodenal bacterial diversity in cirrhosis was distinct to controls showing significantly higher abundances of Streptococcus , Enterococcus and Veillonella . Patients with bactDNA positive ascites revealed reduced spectrum of core microbiota with Streptococcus as key player of duodenal community and higher prevalence of Granulicatella proving presence of cirrhosis related intestinal dysbiosis. Regarding duodenal fluid bactDNA quantification, no significant differences were found between patients with cirrhosis and controls. Additionally, percentage of subjects with detectable bactDNA in blood did not differ between patients and controls. This study evaluated the diversity of bacterial DNA in different body specimens with potential implications on understanding how intestinal bacterial translocation may affect infectious complications in cirrhosis.